BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roodenrijs NMT, Hamar A, Kedves M, Nagy G, van Laar JM, van der Heijde D, Welsing PMJ. Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD Open 2021;7:e001512. [PMID: 33419871 DOI: 10.1136/rmdopen-2020-001512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 He K, He S, Su M. Inter‐alpha‐trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24231] [Reference Citation Analysis]
2 Messelink MA, Roodenrijs NMT, van Es B, Hulsbergen-Veelken CAR, Jong S, Overmars LM, Reteig LC, Tan SC, Tauber T, van Laar JM, Welsing PMJ, Haitjema S. Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon. Arthritis Res Ther 2021;23:184. [PMID: 34238346 DOI: 10.1186/s13075-021-02560-5] [Reference Citation Analysis]
3 Mathias K, Amarnani A, Pal N, Karri J, Arkfeld D, Hagedorn JM, Abd-Elsayed A. Chronic Pain in Patients with Rheumatoid Arthritis. Curr Pain Headache Rep 2021;25:59. [PMID: 34269913 DOI: 10.1007/s11916-021-00973-0] [Reference Citation Analysis]
4 Roodenrijs NMT, Kedves M, Hamar A, Nagy G, van Laar JM, van der Heijde D, Welsing PMJ. Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD Open 2021;7:e001511. [PMID: 33514671 DOI: 10.1136/rmdopen-2020-001511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Roodenrijs NMT, Hamar A, Kedves M, Nagy G, van Laar JM, van der Heijde D, Welsing PMJ. Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD Open 2021;7:e001512. [PMID: 33419871 DOI: 10.1136/rmdopen-2020-001512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Brownlee J, Sheridan E, Synnott A, McCormack A, Bell M, Fitzgerald O. A Lifestyle Management for Arthritis Group education intervention for people with inflammatory and degenerative arthritis: An observational study. Musculoskeletal Care 2021. [PMID: 34894050 DOI: 10.1002/msc.1608] [Reference Citation Analysis]
7 Amstad A, Papagiannoulis E, Scherer A, Rubbert-Roth A, Finckh A, Mueller R, Dudler J, Möller B, Villiger PM, Schulz MMP, Kyburz D. Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy. Rheumatology (Oxford) 2022:keac285. [PMID: 35579338 DOI: 10.1093/rheumatology/keac285] [Reference Citation Analysis]
8 Takanashi S, Kaneko Y, Takeuchi T. Elderly patients with comorbidities in the definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 2021:annrheumdis-2021-220315. [PMID: 33962961 DOI: 10.1136/annrheumdis-2021-220315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Salaffi F, Carotti M, Farah S, Ceccarelli L, Giovagnoni A, Di Carlo M. Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis. Inflammopharmacology 2022. [PMID: 35505266 DOI: 10.1007/s10787-022-00995-z] [Reference Citation Analysis]